Blood Pressure
What Is Blood Pressure?
Blood pressure is the force of blood pushing against the walls of your arteries as your heart pumps. It's expressed as two numbers:
- Systolic pressure (top number): The pressure when your heart beats and pumps blood
- Diastolic pressure (bottom number): The pressure when your heart rests between beats
A reading of "120/80 mmHg" means systolic pressure of 120 millimeters of mercury and diastolic pressure of 80 mmHg.
How HealthKit Stores Blood Pressure
HealthKit can receive blood pressure data from:
- Connected devices: Bluetooth-enabled blood pressure monitors that sync with Apple Health
- Manual entry: User-recorded measurements from any validated device
- Healthcare apps: Third-party apps that write to HealthKit
Unlike heart rate, blood pressure cannot currently be measured directly by Apple Watch and requires a separate cuff-based device for accurate readings.
Scientific Background
Hypertension: The "Silent Killer"
High blood pressure (hypertension) is often called the "silent killer" because it typically causes no symptoms while progressively damaging blood vessels and organs. According to WHO data, hypertension affects approximately 1.3 billion people worldwide and is the leading modifiable risk factor for cardiovascular disease.
Why Blood Pressure Matters:
Elevated blood pressure increases the workload on the heart and damages arterial walls over time, leading to: - Atherosclerosis (arterial plaque buildup) - Heart attack and heart failure - Stroke - Kidney disease - Vision loss - Cognitive decline
Classification Guidelines (ACC/AHA 2017)
The American College of Cardiology and American Heart Association updated blood pressure categories in 2017:
| Category | Systolic | Diastolic | |
|---|---|---|---|
| Normal | < 120 | and | < 80 |
| Elevated | 120-129 | and | < 80 |
| Stage 1 Hypertension | 130-139 | or | 80-89 |
| Stage 2 Hypertension | ≥ 140 | or | ≥ 90 |
| Hypertensive Crisis | > 180 | and/or | > 120 |
These guidelines lowered the threshold for hypertension from 140/90 to 130/80 based on evidence that cardiovascular risk increases at lower levels.
Landmark Research Findings
SPRINT Trial (2015)
The Systolic Blood Pressure Intervention Trial was a landmark NIH-funded study of 9,361 adults at high cardiovascular risk.
Key Findings: - Intensive treatment (target < 120 mmHg) vs. standard (target < 140 mmHg) - 25% reduction in cardiovascular events with intensive treatment - 27% reduction in all-cause mortality - Trial stopped early due to clear benefit of intensive control
"Targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in lower rates of fatal and nonfatal major cardiovascular events and death from any cause." — SPRINT Research Group, NEJM, 2015
Prospective Studies Collaboration (Lancet 2002)
A meta-analysis of 61 prospective studies with 1 million adults demonstrated the continuous relationship between blood pressure and cardiovascular risk:
Key Findings: - The relationship between BP and CVD risk is continuous down to at least 115/75 mmHg - Each 20 mmHg increase in systolic BP doubles cardiovascular mortality risk - Each 10 mmHg increase in diastolic BP doubles cardiovascular mortality risk - This relationship held across all age groups from 40-89 years
Home Blood Pressure Monitoring
A joint policy statement from the American Heart Association and American Medical Association (2020) endorses home blood pressure monitoring as superior to office measurements for:
Clinical Benefits: - More measurements in natural environment - Identifies "white coat hypertension" (elevated only in medical settings) - Identifies "masked hypertension" (normal in office but elevated at home) - Better predicts cardiovascular outcomes than office BP - Improves medication adherence and BP control
Recommended Protocol: - Measure at the same time daily (morning and evening ideal) - Sit quietly for 5 minutes before measuring - Take 2-3 readings, 1 minute apart - Record all readings for healthcare provider review
Clinical Significance
Cardiovascular Risk Assessment
Blood pressure is one of the most important modifiable risk factors for:
| Condition | Risk Increase with Hypertension |
|---|---|
| Stroke | 4-6x higher risk |
| Heart failure | 2-3x higher risk |
| Coronary artery disease | 2-3x higher risk |
| Chronic kidney disease | Progressive increase |
| Atrial fibrillation | 1.5-2x higher risk |
Factors That Influence Blood Pressure
Modifiable factors: - Diet (especially sodium intake) - Physical activity level - Body weight - Alcohol consumption - Stress - Sleep quality
Non-modifiable factors: - Age (BP typically increases with age) - Family history - Race/ethnicity (higher prevalence in Black populations) - Kidney disease
Recommendations
Evidence-Based Guidelines
The 2017 ACC/AHA guidelines recommend:
| Category | Lifestyle Changes | Medication |
|---|---|---|
| Normal | Maintain | Not indicated |
| Elevated | Yes | Not indicated |
| Stage 1 HTN | Yes | If CVD risk > 10% or existing CVD |
| Stage 2 HTN | Yes | Yes, typically 2 medications |
Lifestyle Modifications
Each intervention can reduce systolic BP by approximately:
| Intervention | Expected SBP Reduction |
|---|---|
| DASH diet | 8-14 mmHg |
| Weight loss (10 kg) | 5-20 mmHg |
| Sodium reduction | 2-8 mmHg |
| Physical activity | 4-9 mmHg |
| Moderate alcohol | 2-4 mmHg |
When to Seek Medical Attention
Seek immediate care if blood pressure exceeds 180/120 mmHg, especially with: - Severe headache - Chest pain - Difficulty breathing - Numbness or weakness - Vision changes - Difficulty speaking
Schedule medical evaluation for: - Consistently elevated readings (> 130/80 mmHg) on home monitoring - Wide variations in blood pressure readings - Symptoms like headaches, nosebleeds, or shortness of breath - Medication questions or side effects
References
- Whelton PK, et al. (2018) 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension, 71(6), e13-e115.
- SPRINT Research Group. (2015) A Randomized Trial of Intensive versus Standard Blood-Pressure Control. NEJM, 373(22), 2103-2116.
- Lewington S, et al. (2002) Age-specific relevance of usual blood pressure to vascular mortality. Lancet, 360(9349), 1903-1913.
- Shimbo D, et al. (2020) Self-Measured Blood Pressure Monitoring at Home: AHA/AMA Joint Policy Statement. Circulation, 142(4), e42-e63.
- NCD Risk Factor Collaboration. (2021) Worldwide trends in hypertension prevalence and progress in treatment and control. Lancet, 398(10304), 957-980.
- Staessen JA, et al. (2005) Effects of immediate versus delayed antihypertensive therapy. Journal of Hypertension, 23(6), 1213-1220.